Bempikibart (ADX-914) is under development for the treatment of atopic dermatitis and alopecia areata. It is administered through subcutaneous route and acts by targeting interleukin-7 receptor (IL-7R ...

PF-07832837 is under clinical development by Pfizer and currently in Phase I for Asthma. According to GlobalData, Phase I drugs for Asthma have a 74% phase transition success rate (PTSR) indication ...

VANCOUVER, British Columbia, Dec. 31, 2024 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) ("VERSES'' or the "Company”), a cognitive computing company specializing in next generation ...

Last month the International Energy Agency scrapped its forecast for peak coal consumption, saying use of the world’s ...

The cryptocurrency space is always in the headlines, and almost always for good reasons like a heavy rate of return. Elon ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

AVITA Medical's Q3 report showed strong sequential sales growth and a lower burn rate. My confidence in it reaching breakeven ...

With hydrocarbon demand showing few signs of peaking and shareholder activism waning, oil companies will likely invest more in the upstream and LNG.

At the January 2025 reinsurance renewals broking group Howden estimates that risk-adjusted pricing for property catastrophe ...

For Greenville and Hunt County 2024 was a year of profound loss, transformative milestones and inspiring resilience that underscored the strength of our community. The Herald-Banner's "Our Year in the ...

Hello, Reader. The legendary investor Peter Lynch once said, “Know what you own, and why you own it.” You see, building and ...